Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Item

http://www.wikidata.org/entity/Q33555911

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@ast

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@en

Immunogenicity and safety of a respiratory syncytial virus fusion protein

@nl

type

Item

label

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@ast

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@en

Immunogenicity and safety of a respiratory syncytial virus fusion protein

@nl

prefLabel

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@ast

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@en

Immunogenicity and safety of a respiratory syncytial virus fusion protein

@nl

P1476

Immunogenicity and safety of a ...... ticle vaccine in older adults.

@en

P2093

D Nigel Thomas

http://www.w3.org/2001/XMLSchema#string

Eloi Kpamegan

http://www.w3.org/2001/XMLSchema#string

Gale Smith

http://www.w3.org/2001/XMLSchema#string

Gregory M Glenn

http://www.w3.org/2001/XMLSchema#string

Hanxin Lu

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Stoddard

http://www.w3.org/2001/XMLSchema#string

Louis Fries

http://www.w3.org/2001/XMLSchema#string

Pedro Piedra

http://www.w3.org/2001/XMLSchema#string

Somia P Hickman

http://www.w3.org/2001/XMLSchema#string

Vivek Shinde

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.

Respiratory syncytial virus infection in elderly and high-risk adults.

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

Respiratory syncytial virus infection in adult populations.

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

Respiratory syncytial virus infection in older adults: an under-recognized problem.

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.

P2888

s12979-017-0090-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12979-017-0090-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084762789

http://www.w3.org/2001/XMLSchema#string

P698

28413427

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

nanoparticle

P932

5389002

http://www.w3.org/2001/XMLSchema#string